{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:29:55Z","timestamp":1789543795002,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22590312"],"award-info":[{"award-number":["22590312"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.pathol.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T19:05:10Z","timestamp":1466276710000},"page":"467-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T\/NK-cell neoplasms"],"prefix":"10.1016","volume":"48","author":[{"given":"Lamia","family":"Abdalkader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie P.","family":"Otte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2016.05.002_bib1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin's lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2016.05.002_bib2","first-page":"783","article-title":"Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi","volume":"95","author":"Federico","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.05.002_bib3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1182\/blood-2010-05-287664","article-title":"High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma","volume":"117","author":"Clark","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.05.002_bib4","first-page":"375","article-title":"Diagnostic tools in mycosis fungoides","volume":"145","author":"Humme","year":"2010","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.pathol.2016.05.002_bib5","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.pathol.2016.05.002_bib6","first-page":"165","article-title":"Polycomb-group genes and hematopoiesis","volume":"72","author":"Takihara","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.pathol.2016.05.002_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood.V91.4.1216","article-title":"Stage-specific expression of polycomb group genes in human bone marrow cells","volume":"91","author":"Lessard","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.05.002_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.molcel.2012.01.002","article-title":"PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes","volume":"45","author":"Gao","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.pathol.2016.05.002_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4161\/cc.23550","article-title":"New epigenetic pathway for stemness maintenance mediated by the histone methyltransferase EZH1","volume":"12","author":"Hidalgo","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pathol.2016.05.002_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","article-title":"Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer","volume":"7","author":"Sauvageau","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pathol.2016.05.002_bib11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pathol.2016.05.002_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0092-8674(02)00975-3","article-title":"Drosophila enhancer of Zeste\/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites","volume":"111","author":"Czermin","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2016.05.002_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0092-8674(00)80604-2","article-title":"Stabilization of chromatin structure by PRC1, a Polycomb complex","volume":"98","author":"Shao","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2016.05.002_bib14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.molcel.2004.05.009","article-title":"Hierarchical recruitment of polycomb group silencing complexes","volume":"14","author":"Wang","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.pathol.2016.05.002_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/gb-2005-6-8-227","article-title":"The SET-domain protein superfamily: protein lysine methyltransferases","volume":"6","author":"Dillon","year":"2005","journal-title":"Genome Biol"},{"key":"10.1016\/j.pathol.2016.05.002_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/35020506","article-title":"Regulation of chromatin structure by site-specific histone H3 methyltransferases","volume":"406","author":"Rea","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2016.05.002_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","article-title":"The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3","volume":"14","author":"Cao","year":"2004","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.pathol.2016.05.002_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00412-012-0361-1","article-title":"Inner workings and regulatory inputs that control Polycomb repressive complex 2","volume":"121","author":"O'Meara","year":"2012","journal-title":"Chromosoma"},{"key":"10.1016\/j.pathol.2016.05.002_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1097-2765(04)00185-6","article-title":"Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3","volume":"14","author":"Kuzmichev","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.pathol.2016.05.002_bib20","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/70602","article-title":"Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation","volume":"23","author":"van der Vlag","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2016.05.002_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1242\/dev.121.2.273","article-title":"The eed mutation disrupts anterior mesoderm production in mice","volume":"121","author":"Faust","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.pathol.2016.05.002_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2005.01.5180","article-title":"EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast","volume":"24","author":"Bachmann","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2016.05.002_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2016.05.002_bib24","doi-asserted-by":"crossref","first-page":"10657","DOI":"10.1158\/0008-5472.CAN-07-2498","article-title":"A\u00a0polycomb repression signature in metastatic prostate cancer predicts cancer outcome","volume":"67","author":"Yu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2016.05.002_bib25","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3748\/wjg.v16.i19.2421","article-title":"EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis","volume":"16","author":"Wang","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pathol.2016.05.002_bib26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00428-013-1428-y","article-title":"In aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2","volume":"463","author":"Abd Al Kader","year":"2013","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2016.05.002_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2016.05.002_bib28","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.05.002_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2016.05.002_bib30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.2651","article-title":"Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2016.05.002_bib31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2016.05.002_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/153685902760213859","article-title":"A\u00a0panel of monoclonal antibodies against human Polycomb group proteins","volume":"21","author":"Hamer","year":"2002","journal-title":"Hybrid Hybridomics"},{"key":"10.1016\/j.pathol.2016.05.002_bib33","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1128\/MCB.18.6.3586","article-title":"Characterization of interactions between the mammalian Polycomb-group proteins Enx1\/EZH2 and EED suggests the existence of different mammalian Polycomb- group protein complexes","volume":"18","author":"Sewalt","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pathol.2016.05.002_bib34","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification","volume":"2011","author":"Jaffe","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.pathol.2016.05.002_bib35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/PAS.0000000000000211","article-title":"High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified","volume":"38","author":"Hwang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2016.05.002_bib36","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3109\/10428194.2014.982645","article-title":"Cell of origin predicts outcome to treatment with etopside-containing chemotherapy in young patinents with high risk diffuse large B-cell lymphoma","volume":"56","author":"Gang","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2016.05.002_bib37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.05.002_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.164.1.1","article-title":"Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers","volume":"164","author":"Raaphorst","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2016.05.002_bib39","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.4049\/jimmunol.166.10.5925","article-title":"Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation","volume":"166","author":"Raaphorst","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2016.05.002_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2016.05.002_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4161\/nucl.2.4.16266","article-title":"Composition, recruitment and regulation of the PRC2 complex","volume":"2","author":"Nayak","year":"2011","journal-title":"Nucleus"},{"key":"10.1016\/j.pathol.2016.05.002_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anireprosci.2012.07.006","article-title":"The polycomb group protein EED varies in its ability to access the nucleus in porcine oocytes and cleavage stage embryos","volume":"133","author":"Foust","year":"2012","journal-title":"Anim Reprod Sci"},{"key":"10.1016\/j.pathol.2016.05.002_bib43","doi-asserted-by":"crossref","first-page":"27459","DOI":"10.1074\/jbc.273.42.27459","article-title":"The human WD repeat protein WAIT-1 specifically interacts with the cytoplasmic tails of beta7-integrins","volume":"273","author":"Rietzler","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2016.05.002_bib44","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1158\/1078-0432.CCR-12-0873","article-title":"Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells","volume":"18","author":"Fiskus","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.05.002_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2407-14-139","article-title":"Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS","volume":"14","author":"Ciarapica","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pathol.2016.05.002_bib46","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.yexcr.2013.04.006","article-title":"Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells","volume":"319","author":"Benoit","year":"2013","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.pathol.2016.05.002_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13046-015-0191-0","article-title":"EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches","volume":"34","author":"D'Angelo","year":"2015","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.05.002_bib48","doi-asserted-by":"crossref","first-page":"27023","DOI":"10.18632\/oncotarget.4809","article-title":"Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes","volume":"6","author":"Tiffen","year":"2015","journal-title":"Oncotarget"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251634908X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251634908X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T15:02:31Z","timestamp":1656082951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130251634908X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S003130251634908X"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2016.05.002","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T\/NK-cell neoplasms","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}